Universal Ibogaine (TSXV:IBO) COGS-to-Revenue : 0.00 (As of Apr. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine COGS-to-Revenue?

Universal Ibogaine's Cost of Goods Sold for the three months ended in Apr. 2024 was C$0.00 Mil. Its Revenue for the three months ended in Apr. 2024 was C$0.54 Mil.

Universal Ibogaine's COGS to Revenue for the three months ended in Apr. 2024 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Universal Ibogaine's Gross Margin % for the three months ended in Apr. 2024 was N/A%.

Universal Ibogaine COGS-to-Revenue Historical Data

The historical data trend for Universal Ibogaine's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine COGS-to-Revenue Chart

Universal Ibogaine Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Jul22

Jul23

COGS-to-Revenue

Get a 7-Day Free Trial

Universal Ibogaine Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Universal Ibogaine COGS-to-Revenue Calculation

Universal Ibogaine's COGS to Revenue for the fiscal year that ended in Jul. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	1.03
	=	0.00

Universal Ibogaine's COGS to Revenue for the quarter that ended in Apr. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0.537
	=	0.00

Universal Ibogaine (TSXV:IBO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Universal Ibogaine's Gross Margin % for the three months ended in Apr. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0.537
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Universal Ibogaine COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

IBOGF:USA JC4:Germany

Address

815 8th Avenue South West, Suite 600, Calgary, AB, CAN, T2P 3P2

Website

https://www.universalibogaine.com

Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Executives

Ian Rabb

Senior Officer

Universal Ibogaine Headlines

From GuruFocus

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

By Marketwired • 09-16-2024